E2Pi conducts evidence synthesis and policy analysis on the financing, governance, and architecture of global health aid, with a goal of helping make aid “smarter”—more efficient, effective, and sustainable. We have focused particularly on bilateral and multilateral financing organizations, including three innovative financing partnerships—the Global Fund, the GAVI Alliance, and UNITAID—and the World Bank.
The innovative health funders face a range of complex strategy and policy questions related to their future direction, funding, and business models. E2Pi provides independent analysis and assessment of key issues facing these partnerships, to inform discussion and decision-making at board and committee meetings, and to contribute to broader global health policy debates.
E2Pi’s work on the financing of global health goes beyond questions of aid effectiveness to also examine broader issues—such as domestic financing for health programs and achieving efficiencies and “value for money” in health financing.
Health Systems Funding Platform-A Primer for Policymakers
The Global Fund, GAVI, and the World Bank are developing a new platform to coordinate funding to health systems. In March 2011, E2Pi published a “policy primer” that lays out the Platform’s objectives, principles, and operational framework, describes the current status of implementation, and discusses open issues related to the Platform as it is currently conceived.
Packages of Care—A Pragmatic Approach to Exploring an Enhanced Role for the Global Fund in Maternal, Newborn and Child Health (MNCH)
At its December 2010 Board meeting, the Global Fund Board discussed whether the Fund should increase its support for MNCH. In an E2Pi Working Paper, which was published ahead of the Board meeting, E2Pi “deconstructed” different packages of MNCH interventions (e.g., antenatal care package, child health package) to explore which specific intervention areas within MNCH the Global Fund might be well placed to support.
Estimating Benchmarks of Success in the AMFm pilot phase
The Affordable Medicines Facility - malaria (AMFm), that aims to increase the availability, market share, use, and affordability of artemisin-based combination therapies (ACTs), is being piloted in 8 countries. The Global Fund’s AMFm Ad Hoc Committee (AHC) contracted E2Pi to estimate “benchmarks” of success in this pilot. E2Pi’s analysis, conducted from May 2010 to January 2011, produced recommended benchmarks that were endorsed by the AHC. In March 2011, E2Pi also published a short Policy Brief that summarizes the best evidence to date on whether ACT price subsidies can increase ACT use in malaria-endemic countries and the implications of this evidence for the AMFm.
Five Year External Evaluation of UNITAID
E2PI was sub-contracted to conduct an evaluation of the public health impact of UNITAID. E2PI’s evaluation concluded that “UNITAID-funded projects have contributed significantly to public health outcomes. A majority of projects (55% of the 15 projects that could be assessed for health-related outcomes), making up almost three quarters of UNITAID funding from 2006- 2011, were found to have achieved good or very good health outcomes.”